CClinicalTrials.gg
Active, not recruitingNCT05772325BETTER DietUpdated Jul 8, 2026

The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet in Patients With Inflammatory Joint Disease

An interventional study of Individually tailored diet counseling and The brief standardized 4-minute heart healthy dietary advice in Rheumatoid Arthritis, Psoriatic Arthritis and Spondyloarthritis, sponsored by Diakonhjemmet Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 30 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by Diakonhjemmet Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
30 Years to 80 Years
Sex
All
01

Study summary

A randomized controlled study comparing brief dietary intervention with a personal, tailored dietary advice (60 min) on change in LDL-c and change in diet.

Read the detailed description

Patients with inflammatory joint diseases (IJD) as rheumatoid arthritis (RA), spondylo arthropathy (SpA) and psoriatic arthritis (PsA) are at high risk of atherosclerotic cardiovascular disease. International recommendations for the prevention of cardiovascular disease recommend smoking cessation, physical activity, and dietary changes as part of treatment. Despite the evidence that behavioral counseling reduces overall cardiovascular risk, it is often an overlooked and underemphasized by clinicians. As of today, there is a knowledge gap regarding the efficacy of less intensive counseling sessions needed to obtain changes in dietary habits and clinical effects on CVD risk factors. Therefore, a brief dietary advice would be preferable if it could give a positive change in dietary habits and cholesterol. We have previously shown in a pilot study (8) that a 4 min. brief advice compared to a 60 min. personal tailored advice by a dietician on heart-friendly diet gave a similar change in dietary habits and LDL-c after 8 weeks in patients with IJD. The aim of the Diet Study is to perform a randomized controlled study comparing brief intervention (4 min) with a personal tailored dietary advice (60 min) on change in LDL-c and change in diet.

02

Conditions studied

  • Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Spondyloarthritis
03

In context

Arthritis, Rheumatoid

2,888 studies on the registry are indexed under Arthritis, Rheumatoid; 390 are open to participants now.

This study's planned enrollment of 70 is below the median of 94 across 1,984 interventional studies indexed under Arthritis, Rheumatoid.

Browse Arthritis, Rheumatoid studies →

Lead sponsor

Diakonhjemmet Hospital is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with either RA, PsA, or AS, between 30-80 years with an increased risk of future CVD, estimated using the CVD risk calculator. i.e. any risk > 5 -10 % predicted by Systematic Coronary Risk Evaluation (SCORE2) algorithm. Also, patients with very high risk (predicted risk >10%) as well as established atherosclerotic CVD (ASCVD) including previous myocardial infarction, coronary intervention (coronary artery bypass grafting or percutaneous coronary intervention), transient ischemic attack/strokes, atherosclerotic diseases of arteries as in the carotid artery or peripheral arterial disease (PAD) will also be included.

Exclusion criteria

Exclusion Criteria:

  1. Heart failure with systolic EF\<40%
  2. Kidney failure with GFR \< 35
  3. Liver failure
  4. Mental disorder rendering the patient unable to comply with the protocol
  5. Being able to speak the language of the country
  6. Reduced cognitive function
  7. Substance abuse
  8. Recent initiation or change in doses of lipid-lowering therapy or weight loss medication
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Active comparator
    Brief standardized dietary advice

    The brief standardized 4-minute heart healthy dietary advice will be provided by an experienced cardiologist or rheumatologists.

    Other: The brief standardized 4-minute heart healthy dietary advice

  • Experimental
    Individually tailored diet counseling

    Participants in the intervention group will receive a 60 min individually tailored heart-friendly diet consultation by a dietitian.

    Other: Individually tailored diet counseling

Interventions

  • OtherIndividually tailored diet counseling

    Participants in the intervention group will receive a 60 min individually tailored heart-friendly diet consultation by a dietitian

  • OtherThe brief standardized 4-minute heart healthy dietary advice

    The brief standardized 4-minute heart healthy dietary advice will be provided by an experienced cardiologist or rheumatologists

06

What researchers measure

Primary outcomes

  1. LDL cholesterol change from baseline

    LDL cholesterol change from baseline

    Time frame: 8 weeks

Secondary outcomes

  1. Change in Healthy Diet Score (HDS) according to SmartDiet score

    A self-administered 15-item food-frequency questionnaire (SmartDiet™) will be applied to assess subjects' average intake of: dairy products, mayonnaise products, meat, grain, fish, fruit, vegetables and snacks. The questionnaire has three response categories: Least healthy (1 point), Medium healthy (2 points) and Most healthy (3 points). The scores on the 15 questions are summed to obtain a Healthy Diet Score (HDS) ranging from 15 (worst) to 45 points (best). A change in the sum score of \> 3 is considered a (clinical) significant change in diet.

    Time frame: 8 weeks

07

Study locations

1 site
  • Diakonhjemmet Hospital
    Oslo, 0370, Norway
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05772325
Lead sponsor
Diakonhjemmet Hospital
Collaborators
University Hospital, Umeå
Responsible party
Sponsor
First posted
Mar 16, 2023
Start date
Feb 20, 2023
Primary completion
Aug 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Jul 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion